CEACAM6 and IFITM3 as potential biomarkers for pelareorep in pancreatic adenocarcinoma (PDAC).

Authors: Noonan, Anne M., David, Jason, Hays, John L., Chen, James Lin

Source: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p684-684, 117p

Results of the phase 1b soft-tissue sarcoma (STS) portion of the global randomized, double-blind, placebo-controlled study of tazemetostat (TAZ) plus doxorubicin (DOX) as frontline therapy for advanced epithelioid sarcoma (ES).

Authors: Chawla, Sant P., Falchook, Gerald Steven, Burgess, Melissa Amber, Chen, James Lin, Jones, Robin Lewis, Chua, Victoria S., Tapia, Coya, Ainscough, Jessica, Hamlett, Anthony, Merchant, Melinda S., Chugh, Rashmi

Source: Journal of clinical oncology. 39(15 suppl):11563-11563

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173107127.0x000001&indx=1&recIds=ETOCvdc_100173107127.0x000001

The sarcoma microbiome as a diagnostic and therapeutic target.

Authors: Tinoco, Gabriel, Husain, Marium, Hoyd, Rebecca, Jagjit Singh, Malvenderjit, Liu, YunZhou, Mo, Xiaokui, Chen, James Lin, Liebner, David A., Spakowicz, Daniel

Source: Journal of clinical oncology. 39(15 suppl):11541-11541

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173106491.0x000001&indx=1&recIds=ETOCvdc_100173106491.0x000001

Demographics, outcomes, and risk factors for patients (Pts) with sarcoma and COVID-19: A multi-institutional cohort analysis.

Authors: Wagner, Michael J, Ingham, Matthew, Painter, Corrie, Chugh, Rashmi, Trent, Jonathan C., Subbiah, Vivek, Khaki, Ali Raza, Tachiki, Lisa May Ling, Loggers, Elizabeth Trice, Labaki, Chris, McKay, Rana R., Griffiths, Elizabeth A., Thornton, Katherine Anne, Kasi, Anup, Hwang, Clara, Chen, James Lin, Halfdanarson, Thorvardur Ragnar, Reuben, Daniel Y., Park, Cathleen, Davis, Elizabeth J.

Source: Journal of clinical oncology. 39(15 suppl):11523-11523

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173105998.0x000001&indx=1&recIds=ETOCvdc_100173105998.0x000001

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Authors: Ingham, Matthew, Allred, Jacob B., Gano, Katherine, George, Suzanne, Attia, Steven, Burgess, Melissa Amber, Seetharam, Mahesh, Boikos, Sosipatros Alexandros, Bui, Nam, Chen, James Lin, Close, Julia Lee, Cote, Gregory Michael, Thaker, Premal H., Ivy, S. Percy, Das, Biswajit, Shapiro, Geoffrey, Kochupurakkal, Bose, Trepel, Jane B., Pommier, Yves, Schwartz, Gary K.

Source: Journal of clinical oncology. 39(15 suppl):11506-11506

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173105556.0x000001&indx=1&recIds=ETOCvdc_100173105556.0x000001

Chondrosarcoma: The OSU experience.

Authors: Husain, Marium, Tinoco, Gabriel, Chen, James Lin, Mayerson, Joel L, Scharschmidt, Thomas, Alexander, John, Konieczkowski, David Joseph, Haglund, Karl, Grignol, Valerie Patrice, Beane, Joal, Kim, Hangil, Xu, Menglin, Liebner, David A.

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe23505-e23505, 1p

Exchanging genomics reports between pathology labs and medical centers using the Minimal Clinical Oncology Data Element (mCODE) FHIR implementation guide.

Authors: Terry, May, Anton, Howard, Casagni, Michelle, Chamala, Srikar, Chen, James Lin

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe13575-e13575, 1p

Time savings from integrating discrete, genomic data into the electronic health record using the Epic Aura Network.

Authors: Posteraro, Leo, Mergler, Patrick, Urbanek, Dennis, Schulin, Joseff, Anton, Howard, Kokkinos, Nancy, Chen, James Lin

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe13568-e13568, 1p

DCK expression by RNAseq as a potential biomarker of gemcitabine response in sarcoma.

Authors: Liebner, David A., Fetzer, Erin A, Husain, Marium, Chen, James Lin, Tinoco, Gabriel

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p11578-11578, 1p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.